Therapie der diabetischen Neuropathie

D. Ziegler; A. Bierhaus

doi:10.1055/s-2007-979379

DMW - Deutsche Medizinische Wochenschrift, Table of Contents

Dtsch Med Wochenschr 2007; 132(19): 1043-1047
DOI: 10.1055/s-2007-979379

Aktuelle Diagnostik & Therapie | Review article

Diabetologie, Neurologie
© Georg Thieme Verlag KG Stuttgart · New York

Therapie der diabetischen Neuropathie

Treatment of diabetic neuropathyD. Ziegler¹ , A. Bierhaus²

¹Institut für Klinische Diabetologie, Deutsches Diabetes-Zentrum, Leibniz-Institut an der Heinrich-Heine-Universität Düsseldorf
²Abteilung Innere Medizin I und Klinische Chemie, Medizinische Klinik, Universitätsklinikum Heidelberg

Abstract

Schlüsselwörter

Diabetes mellitus - diabetische Neuropathie - Polyneuropathie - Schmerztherapie

Key words

diabetes mellitus - diabetic neuropathy - polyneuropathy - treatment of neuropathic pain

Full Text

References

Literatur

1 Backonja M, Beydoun A, Edwards K R, Schwartz S L, Fonseca V, Hes M, LaMoreaux L, Garofalo E. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. J Am Med Assoc. 1998; 280 1831-1836
2 Bierhaus A, Haslbeck K M, Humpert P M, Liliensiek B, Dehmer T, Morcos M, Sayed A A, Andrassy M, Schiekofer S, Schneider J G. et al . Loss of pain perception in diabetes is dependent on a receptor of the immunoglobulin superfamily. J Clin Invest. 2004; 114 1741-1751
3 Bierhaus A, Humpert P M, Morcos M, Wendt T, Chavakis T, Arnold B, Stern D M, Nawroth P P. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med. 2005; 83 876-886
4 Bierhaus A, Humpert P M, Rudofsky G, Wendt T, Morcos M, Hamann A, Nawroth P P. New treatments for diabetic neuropathy: pathogenetically oriented treatment. Curr Diab Rep. 2003; 3 452-458
5 Bosi E, Conti M, Vermigli C, Cazzetta G, Peretti E, Cordoni M C, Galimberti G, Scionti L. Effectiveness of frequency-modulated electromagnetic neural stimulation in the treatment of painful diabetic neuropathy. Diabetologia. 2005; 48 817-823
6 Boulton A J, Vinik A I, Arezzo J C, Bril V, Feldman E L, Freeman R, Malik R A, Maser R E, Sosenko J M, Ziegler D. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005; 28 956-962
7 Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005; 54 1615-1625
8 Daousi C, MacFarlane I A, Woodward A, Nurmikko T J, Bundred P E, Benbow S J. Chronic painful peripheral neuropathy in an urban community: a controlled comparison of people with and without diabetes. Diabet Med. 2004; 21 976-982
9 Davies M, Brophy S, Williams R, Taylor A. The prevalence, severity, and impact of painful diabetic peripheral neuropathy in type 2 diabetes. Diabetes Care. 2006; 29 1518-1522
10 Dogra S, Beydoun S, Mazzola J, Hopwood M, Wan Y. Oxcarbazepine in painful diabetic neuropathy: a randomized, placebo-controlled study. Eur J Pain. 2005; 9 543-554
11 Eichberg J. Protein kinase C changes in diabetes: is the concept relevant to neuropathy?. Int Rev Neurobiol. 2002; 50 61-82
12 Finnerup N B, Otto M, McQuay H J, Jensen T S, Sindrup S H. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain. 2005; 118 289-305
13 Garcia-Ruiz C, Colell A, Morales A, Kaplowitz N, Fernandez-Checa J C. Role of oxidative stress generated from the mitochondrial electron transport chain and mitochondrial glutathione status in loss of mitochondrial function and activation of transcription factor nuclear factor-kappa B: studies with isolated mitochondria and rat hepatocytes. Mol Pharmacol. 1995; 48 825-834
14 Gilron I, Bailey J M, Tu D, Holden R R, Weaver D F, Houlden R L. Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med. 2005; 352 1324-1334
15 Gimbel J S, Richards P, Portenoy R K. Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial. Neurology. 2003; 60 927-934
16 Goldstein D J, Lu Y, Detke M J, Lee T C, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 2005; 116 109-118
17 Griesing T, Freeman R, Rosenstock J, Sharma U, LaMoreaux L, Emir B, Siffert J. Efficacy, safety, and tolerability of pregabalin treatment for diabetic peripheral neuropathy: findings from 6 randomized controlled trials. Diabetologia. 2005; 48 (suppl 1) A351
18 Harati Y, Gooch C, Swenson M, Edelman S, Greene D, Raskin P, Donofrio P, Cornblath D, Sachdeo R, Siu C O. et al . Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology. 1998; 50 1842-1846
19 Haslbeck M, Luft D, Neundörfer B, Stracke H, Ziegler D. Diagnostik, Therapie und Verlaufskontrolle der Neuropathie bei Diabetes mellitus Typ 1 und Typ 2. http://wwwdeutsche-diabetes-gesellschaftde/redaktion/mitteilungen/leitlinien/Leitlinie_ neuropathiepdf 2006
20 Ho E C, Lam K S, Chen Y S, Yip J C, Arvindakshan M, Yamagishi S, Yagihashi S, Oates P J, Ellery C A, Chung S S. et al . Aldose reductase-deficient mice are protected from delayed motor nerve conduction velocity, increased c-Jun NH2-terminal kinase activation, depletion of reduced glutathione, increased superoxide accumulation, and DNA damage. Diabetes. 2006; 55 1946-1953
21 Jensen T S, Backonja M M, Hernandez Jimenez S, Tesfaye S, Valensi P, Ziegler D. New perspectives on the management of diabetic peripheral neuropathic pain. Diab Vasc Dis Res. 2006; 3 108-119
22 Mason L, Moore R A, Derry S, Edwards J E, McQuay H J. Systematic review of topical capsaicin for the treatment of chronic pain. Bmj. 2004; 328 991-995
23 Obrosova I G. How does glucose generate oxidative stress in peripheral nerve?. Int Rev Neurobiol. 2002; 50 3-35
24 Raskin J, Pritchett Y L, Wang F, D’Souza D N, Waninger A L, Iyengar S, Wernicke J F. A double-blind, randomized multicenter trial comparing duloxetine with placebo in the management of diabetic peripheral neuropathic pain. Pain Med. 2005; 6 346-356
25 Reichstein L, Labrenz S, Ziegler D, Martin S. Effective treatment of symptomatic diabetic polyneuropathy by high-frequency external muscle stimulation. Diabetologia. 2005; 48 824-828
26 Thienel U, Neto W, Schwabe S K, Vijapurkar U. Topiramate in painful diabetic polyneuropathy: findings from three double-blind placebo-controlled trials. Acta Neurol Scand. 2004; 110 221-231
27 Vincent A M, Russell J W, Low P, Feldman E L. Oxidative stress in the pathogenesis of diabetic neuropathy. Endocr Rev. 2004; 25 612-628
28 Vinik A I, Tuchman M, Safirstein B, Corder C, Kirby L, Wilks K, Quessy S, Blum D, Grainger J, White J. et al . Lamotrigine for treatment of pain associated with diabetic neuropathy: results of two randomized, double-blind, placebo-controlled studies. Pain. 2007; 128 169-179
29 Vinik A I, Vinik E. Prevention of the complications of diabetes. Am J Manag Care. 2003; (3 Suppl) 9 S63-80; quiz S81 - 64
30 Wernicke J F, Pritchett Y L, D’Souza D N, Waninger A, Tran P, Iyengar S, Raskin J. A randomized controlled trial of duloxetine in diabetic peripheral neuropathic pain. Neurology. 2006; 67 1411-1420
31 Ziegler D, Ametov A, Barinov A, Dyck P J, Gurieva I, Low P A, Munzel U, Yakhno N, Raz I, Novosadova M. et al . Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care. 2006; 29 2365-2370
32 Ziegler D, Nowak H, Kempler P, Vargha P, Low P A. Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis. Diabet Med. 2004; 21 114-121
33 Ziegler D, Pritchett Y L, Wang F, Desaiah D, Robinson M, Hall J, Chappell A. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain. Diabetes Care. 2007; 30 664-669
34 Ziegler D. Treatment of diabetic polyneuropathy: Update 2006. Ann N Y Acad Sci. 2006; 1084 250-266
35 Hammes H P, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P P, Hannak D, Neumeier M, Bergfeld R, Giardino I, Brownlee M. Benfotiamine blocks three Major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003; 9 294-299

Prof. Dr. med. Dan Ziegler

Deutsches Diabetes-Zentrum, Leibniz-Institut an der Heinrich-Heine-Universität

Auf’m Hennekamp 65

40225 Düsseldorf

Phone: 0211/33821

Fax: 0211/3382277

Email: dan.ziegler@ddz.uni-duesseldorf.de